Page 2 - Delivery Technologies News Today

Medtech startup Metyos has secured €2.3 million in pre-seed funding to advance its mission of improving the lives of chronic kidney disease (CKD) patients worldwide.

"According to the latest BCC Research study, the demand for Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials is estimated to increase from $55.8 billion in 2023 to reach $88.9 billion by 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028."

Today (March 26) One2Treat, a progressive startup specializing in digital health solutions, has launched a forward-thinking approach aimed at tackling key challenges in the biopharma industry.

Greater integration is to take place between the US and UK following an expansion says Cresset, a provider of integrated in-silico solutions for drug discovery.

In a bid to reshape the landscape of targeted antibody design, AION a creative venture studio based in Israel has introduced CombinAble.AI.

As the landscape of healthcare continues to evolve, so too does the field of drug delivery.

Connectivity for research site processes and research has strengthened significantly following a partnership between Florence Healthcare and Slope.

Dsm-firmenich, today (February 15) announces its exclusive partnership with Zerion Pharma A/S to unlock a new era in cannabinoid innovation that champions patient-centric formulations.

At most major conferences, there is usually a topic or buzzword that everyone talks about - and at this year’s SCOPE held in Orlando this week, it was no different.

With independent pharmacies now facing significant challenges, healthcare SaaS provider Charac was pleased to announce more investment so it can accelerate a digitization drive.